Sanofi SA (SASY)

Xetra
Currency in EUR
103.700
-0.380(-0.37%)
Closed

SASY Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa37,36939,17540,30441,10944,286
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-0.7%+4.83%+2.88%+2%+7.73%
Cost of Revenue
aa.aaaa.aaaa.aaaa.aaaa.aa12,10612,25111,86912,61913,195
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa25,26326,92428,43528,49031,091
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-1.53%+6.57%+5.61%+0.19%+9.13%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa67.6%68.73%70.55%69.3%70.21%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa17,68418,35918,05420,36922,222
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-6.2%+3.82%-1.66%+12.82%+9.1%
aa.aaaa.aaaa.aaaa.aaaa.aa5,5305,6926,5016,5077,394
aa.aaaa.aaaa.aaaa.aaaa.aa9,4489,5998,7859,0039,247
aa.aaaa.aaaa.aaaa.aaaa.aa1,0251,4881,1902,9483,832
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa7,5798,56510,3818,1218,869
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+11.42%+13.01%+21.2%-21.77%+9.21%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa20.28%21.86%25.76%19.75%20.03%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-422-359-163-62-228
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+6.84%+14.93%+54.6%+61.96%-267.74%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-459-362-402-589-641
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa373239527413
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa49711138-712-202
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa7,6548,31710,2567,3478,439
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa443418481484539
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-206-77344-676-814
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa14,1377,8379,9926,1156,758
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+370.14%-44.56%+27.5%-38.8%+10.52%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa37.83%20.01%24.79%14.88%15.26%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1,8071,5581,9091,0171,204
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa12,3306,2798,4845,4365,618
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-36-56-113-36-58
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa12,2946,2238,3715,4005,560
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+346.41%-49.38%+34.52%-35.49%+2.96%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa32.9%15.89%20.77%13.14%12.55%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa12,2946,2237,9705,0625,496
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa9.814.976.374.044.39
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+329.34%-49.34%+28.13%-36.48%+8.6%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa9.764.956.354.044.39
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+329.96%-49.28%+28.28%-36.31%+8.55%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,253.61,252.51,251.91,251.71,251.4
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,260.11,257.91,256.91,256.41,256.1
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa3.23.333.563.763.92
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1.59%+4.06%+6.91%+5.62%+4.26%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa10,46611,25114,88011,07611,848
EBITDA Growth
aa.aaaa.aaaa.aa